drug

pralatrexate

1 story · latest Aug 6, 2026

Status: FDA approved Sep 2009 · NDA022468
Brand: Folotyn
Trials: 1 registered trial in coverage

Relationships

Developed by Fresenius Kabi

Timeline

Corvus reports Q2 2026 results, updates soquelitinib pipeline progress

Aug 6Quarterly updateCorvus Pharmaceuticals, Inc.soquelitinib

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.